Suppr超能文献

甲状旁腺疾病中的血浆维生素D代谢产物(作者译)

[Plasma vitamin D metabolites in parathyroid diseases (author's transl)].

作者信息

Unakami H

出版信息

Nihon Naibunpi Gakkai Zasshi. 1982 Mar 20;58(3):234-47. doi: 10.1507/endocrine1927.58.3_234.

Abstract

The basal values of plasma vitamin D metabolites were evaluated in patients with primary hyperparathyroidism (1 degree HPT, n = 31), hypoparathyroidism (HP, n = 7), pseudohypoparathyroidism (PHP, n = 4) and normal controls (n = 21). Plasma 25-hydroxyvitamin D (25-OH-D) in 1 degree HPT (9.0 +/0 7.3 ng/ml, mean SD) was significantly lower than that of normal controls (17.9 +/- 5.5ng/ml)(p less than 0.001), and in particular 1 degree HPT classified as the skeletal type showed extremely low value (4.7 +/- 4.6 ng/ml). Plasma 1, 25-dihydroxyvitamin D [1, 25-(OH)2D] was significantly higher in 1 degree HPT (69.1 +/- 31.4pg/ml)(p less than 0.001) and significantly lower in Hp (15.2 +/- 11.0 pg/ml) (p less than 0.001) compared to normal controls (37.2 +/- 13.8pg/ml), although there was no significant difference in PHP (22.3 +/- 17.5 pg/ml). Plasma 24, 25-dihydroxyvitamin D [24,, 25-(OH)2D] in 1 degree HPT (1.06 +/- 0.55 ng/ml) was significantly lower than that of normal controls (1.73 +/- 0.62 ng/ml) (p less than 0.05), and particularly 1 degree HPT classified as the skeletal type showed a marked low value (0.85 +/- 0.27 ng/ml), whereas no significant differences were seen in HP (1.84 +/- 0.46 ng/ml) or PHP (1.34 +/- 0.22 ng/ml). There were slight but significant correlations between either plasma 25-OH-D and 1, 25-(OH)2D (r = -0.350, p less than 0.05), or plasma 25-OH-D and 24, 25-(OH)2D (r = 0.356, p less than 0.05), or plasma 1, 25-(OH)2D and 24, 25-(OH)2D (r = -0.444, p less than 0.01) in all subjects. In addition, relationships between plasma vitamin D metabolites and other indicators of parathyroid function in all subjects were analyzed. There were positive correlations between plasma 1, 25-(OH)2D and serum Ca (r = -0.621, p less than 0.001) or urinary cAMP (r = -0.671, p less than 0.001) or nephrogenous cAMP (r = -0.689, p less than 0.001), while negative correlations were seen between plasma 1, 25-(OH)2D and serum P (r = -0.680, p less than 0.001) or %TRP (r = -0.663, p less than 0.001). On the other hand, there were negative correlations between plasma 24, 25-(OH)2D and serum Ca (r = -0.457, p less than 0.01) or urinary cAMP (r = -0.562, p less than 0.005) or nephrogenous cAMp (r = -0.561, p less than 0.005), and a positive correlation was seen between plasma 24, 25-(OH)2D and %TRP (r = 0.519, p less than 0.005). After parathyroidectomy, a distinct depression of plasma 1, 25-(OH)2D and reciprocal elevation of plasma 24, 25-(OH)2D were observed in 1 degree HPT. Furthermore, there was a clear elevation of plasma 24, 25-(OH)2D as well as plasma 1, 25-(OH)2D after treatment with maintenance doses of 1 alpha-OH-D3 or 1 alpha, 25-(OH)2D3 in HP and PHP. It is concluded that plasma vitamin D metabolites are very useful as the indicators of parathyroid function.

摘要

对原发性甲状旁腺功能亢进症患者(1度甲状旁腺功能亢进,n = 31)、甲状旁腺功能减退症患者(甲状旁腺功能减退,n = 7)、假性甲状旁腺功能减退症患者(假性甲状旁腺功能减退,n = 4)和正常对照组(n = 21)的血浆维生素D代谢物基础值进行了评估。1度甲状旁腺功能亢进患者的血浆25-羟基维生素D(25-OH-D)(9.0±7.3 ng/ml,均值±标准差)显著低于正常对照组(17.9±5.5 ng/ml)(p<0.001),尤其是归类为骨骼型的1度甲状旁腺功能亢进患者其值极低(4.7±4.6 ng/ml)。与正常对照组(37.2±13.8 pg/ml)相比,1度甲状旁腺功能亢进患者的血浆1,25-二羟基维生素D[1,25-(OH)2D]显著升高(69.1±31.4 pg/ml)(p<0.001),甲状旁腺功能减退患者显著降低(15.2±11.0 pg/ml)(p<0.001),而假性甲状旁腺功能减退症患者(22.3±17.5 pg/ml)无显著差异。1度甲状旁腺功能亢进患者的血浆24,25-二羟基维生素D[24,25-(OH)2D](1.06±0.55 ng/ml)显著低于正常对照组(1.73±0.62 ng/ml)(p<0.05),特别是归类为骨骼型的1度甲状旁腺功能亢进患者显示出明显的低值(0.85±0.27 ng/ml),而甲状旁腺功能减退患者(1.84±0.46 ng/ml)或假性甲状旁腺功能减退症患者(1.34±0.22 ng/ml)无显著差异。在所有受试者中,血浆25-OH-D与1,25-(OH)2D之间(r = -0.350,p<0.05)、血浆25-OH-D与24,25-(OH)2D之间(r = 0.356,p<0.05)或血浆1,25-(OH)2D与24,25-(OH)2D之间(r = -0.444,p<0.01)均存在轻微但显著的相关性。此外,分析了所有受试者血浆维生素D代谢物与甲状旁腺功能其他指标之间的关系。血浆1,25-(OH)2D与血清钙(r = -0.621,p<0.001)、尿环磷腺苷(r = -0.671,p<0.001)或肾源性环磷腺苷(r = -0.689,p<0.001)之间呈正相关,而血浆1,25-(OH)2D与血清磷(r = -0.680,p<0.001)或%TRP(r = -0.663,p<0.001)之间呈负相关。另一方面,血浆24,25-(OH)2D与血清钙(r = -0.457,p<0.01)、尿环磷腺苷(r = -0.562,p<0.005)或肾源性环磷腺苷(r = -0.561,p<0.005)之间呈负相关,血浆24,25-(OH)2D与%TRP之间呈正相关(r = 0.519,p<0.005)。甲状旁腺切除术后,1度甲状旁腺功能亢进患者观察到血浆1,25-(OH)2D明显降低,血浆24,25-(OH)2D相应升高。此外,在甲状旁腺功能减退症和假性甲状旁腺功能减退症患者中,给予维持剂量的1α-羟基维生素D3或1α,25-(OH)2D3治疗后,血浆24,25-(OH)2D以及血浆1,25-(OH)2D均明显升高。结论是血浆维生素D代谢物作为甲状旁腺功能指标非常有用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验